Literature DB >> 7448713

Epidemiologic features of rapidly progressing breast cancer in Tunisia.

N Mourali, L R Muenz, F Tabbane, S Belhassen, J Bahi, P H Levine.   

Abstract

A form of breast cancer characterized by rapid disease progression, inflammation, and edema is found in approximately 55% of the breast cancer patients presenting at the Institute Salah Azaiz, Tunis (Tunisia). In 581 patients seen between January 1, 1969, and December 31, 1974, we examined age, place of residence, reproductive history, delay in seeking treatment, and blood gropu as potential risk factors to determine the distinction between the rapidly progressing disease and the less aggressive form. Rural residence, blood type A, and recent pregnancy are risk factors among premenopausal women, but older age, rural residence, blood type A, late menarche, and delay in diagnosis are associated with postmenopausal rapidly progressing breast cancer. The most significant risk factors were rural residence and blood type A. Rapidly progressing breast cancer was diagnosed in two of every three breast cancer patients coming from a rural environment. Forty-three percent of 203 patients with rapid disease progression were blood type A, a significantly higher percentage than the 33% found in the general Tunisian population and the breast cancer patients without evidence of rapidly progressive disease. We observed that the risk factors for disease progression were quite different from those reported to influence the incidence of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7448713     DOI: 10.1002/1097-0142(19801215)46:12<2741::aid-cncr2820461234>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

Review 1.  Inflammatory breast cancer: what we know and what we need to learn.

Authors:  Hideko Yamauchi; Wendy A Woodward; Vicente Valero; Ricardo H Alvarez; Anthony Lucci; Thomas A Buchholz; Takayuki Iwamoto; Savitri Krishnamurthy; Wei Yang; James M Reuben; Gabriel N Hortobágyi; Naoto T Ueno
Journal:  Oncologist       Date:  2012-05-14

2.  ABO blood groups in relation to breast carcinoma incidence and associated prognostic factors in Moroccan women.

Authors:  S Zouine; F Marnissi; N Otmani; M Bennani Othmani; M El Wafi; K Kojok; Y Zaid; N Tahiri Jouti; N Habti
Journal:  Med Oncol       Date:  2016-05-30       Impact factor: 3.064

3.  Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.

Authors:  Kenneth W Hance; William F Anderson; Susan S Devesa; Heather A Young; Paul H Levine
Journal:  J Natl Cancer Inst       Date:  2005-07-06       Impact factor: 13.506

Review 4.  Inflammatory breast cancer clusters: A hypothesis.

Authors:  Paul H Levine; Salman Hashmi; Ashley A Minaei; Carmela Veneroso
Journal:  World J Clin Oncol       Date:  2014-08-10

5.  Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients.

Authors:  Nabila Chaher; Hugo Arias-Pulido; Nadija Terki; Clifford Qualls; Kamel Bouzid; Claire Verschraegen; Anne Marie Wallace; Melanie Royce
Journal:  Breast Cancer Res Treat       Date:  2011-03-01       Impact factor: 4.872

6.  Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients.

Authors:  Sondes Karray-Chouayekh; Fatma Trifa; Abdelmajid Khabir; Nouredine Boujelbane; Tahia Sellami-Boudawara; Jamel Daoud; Mounir Frikha; Rachid Jlidi; Ali Gargouri; Raja Mokdad-Gargouri
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-06       Impact factor: 4.553

7.  Breast cancer characteristics at diagnosis and survival among Arab-American women compared to European- and African-American women.

Authors:  Sharon Hensley Alford; Kendra Schwartz; Amr Soliman; Christine Cole Johnson; Stephen B Gruber; Sofia D Merajver
Journal:  Breast Cancer Res Treat       Date:  2008-04-15       Impact factor: 4.872

8.  Defining a global research agenda for breast cancer.

Authors:  Richard R Love
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

9.  A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009.

Authors:  Kelly A Hirko; Amr S Soliman; Mousumi Banerjee; Julie Ruterbusch; Joe B Harford; Sofia D Merajver; Kendra Schwartz
Journal:  Breast J       Date:  2013-12-26       Impact factor: 2.431

10.  Clinical significance of epigenetic inactivation of hMLH1 and BRCA1 in Tunisian patients with invasive breast carcinoma.

Authors:  Sondes Karray-Chouayekh; Fatma Trifa; Abdelmajid Khabir; Nouredine Boujelbane; Tahia Sellami-Boudawara; Jamel Daoud; Mounir Frikha; Ali Gargouri; Raja Mokdad-Gargouri
Journal:  J Biomed Biotechnol       Date:  2009-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.